PFKFB4 and hemoglobin measurement: Based on the expression levels of these two markers, DNMT3B and PFKFB4, a metabolic score (meta.score) was calculated, and this score was found to be significantly different between HB tumors with positive and negative metastasis status (two-sided t-test, p-value = 0.0054; Figure 3D).